Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (16544)	3/5/1998 1:43:00 PM
From: Andrew H	Read Replies (1) \| Respond to of 32384

Sounds good, Henry. I guess we will see LGND branching into CNS without making any efforts--kind of like diabetes and obesity. Just the side effects of great drugs and research. Stock is holding strong in the face of a heavy market decline, altho no nearly as bad as I was prepared for. Very bullish. LGND will be moving higher very soon!

To: Henry Niman who wrote (16544)	3/5/1998 2:46:00 PM
From: Flagrante Delictu	Read Replies (3) \| Respond to of 32384

Henry, >> If estrogen does prove to help prevent dementia, it would be of major public health importance <<. At one of the b/t conferences I attended this past fall, I raised my hand to ask a question during the LGND breakout session. By the time I was recognized by the floor, I had forgotten the question, and, jokingly commented that I was a victim of "old timers disease". DR immediately responded that they thought they had a solution for not only Alzheimer's disease but also cognition impairment. They indicated they were working on estrogen therapy to beneficially impact these conditions. I would expect a big push in the area of Central Nervous System disorders via a new collaboration. Bernie